Expression of ghrelin and leptin during the development of type 2 diabetes mellitus in a rat model

Zhang,Songyun; Zhang,Qingjiu; Zhang,Lihui; Li,Cege; Jiang,Huiqing

doi:10.3892/mmr.2012.1154

Expression of ghrelin and leptin during the development of type 2 diabetes mellitus in a rat model

Authors:
- Songyun Zhang
- Qingjiu Zhang
- Lihui Zhang
- Cege Li
- Huiqing Jiang
View Affiliations

Affiliations: Department of Endocrinology, The Second Hospital of Hebei Medical University, Shijiazhuang 050000, P.R. China, Department of Neurosurgery, The Second Hospital of Hebei Medical University, Shijiazhuang 050000, P.R. China, Department of Gastroenterology, Hebei Key Laboratory of Gastroenterology, Hebei Institute of Gastroenterology, The Second Hospital of Hebei Medical University, Shijiazhuang 050000, P.R. China
Published online on: October 25, 2012 https://doi.org/10.3892/mmr.2012.1154
Pages: 223-228

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of this study was to investigate the systematic changes in ghrelin and leptin expression, as well as their correlation with insulin resistance (IR) during the development of type 2 diabetes mellitus (T2DM) in a rat model. T2DM was induced in rats fed a high-fat (HF)-diet followed by the intraperitoneal injection of low-dose streptozotocin (STZ, 35 mg/kg). Sixty male Sprague-Dawley rats were divided into 4 groups: the control, HF-4W (HF diet for 4 weeks), HF-8W (HF diet for 8 weeks) and the T2DM group. During the development of T2DM, the production of ghrelin in the stomach and leptin in adipose tissue, the blood levels of ghrelin and leptin, and the expression of leptin and ghrelin receptors (OB-Rb and GHS-R1a) in the hypothalamus were measured by enzyme-linked immunosorbent assay (ELISA), radioimmunology assay (RIA), immunohistochemistry (IHC) and real-time reverse transcription-polymerase chain reaction (real-time RT-PCR). IR was assessed using the hyperinsulinemic-euglycemic clamp technique. The production of ghrelin in the stomach, the plasma ghrelin levels and the expression of GHS-R1a in the hypothalamus were significantly reduced in the HF-4W and HF-8W rats compared with the control rats; however, no significant difference was found between the HF-8W and T2DM group rats. Comparing the control to the T2DM group, the production of leptin in the adipose tissue and the serum leptin levels increased, whereas the expression of OB-Rb in the hypothalamus decreased. At the same time, the glucose infusion rate (GIR), indicating the insulin sensitivity, decreased significantly; GIR positively correlated with plasma ghrelin and negatively correlated with serum leptin levels. In conclusion, increased leptin levels are associated with obesity and T2DM, while decreased ghrelin levels are associated with obesity/IR rather than T2DM.

View Figures

View References

1	Yang W, Lu J, Weng J, et al: Prevalence of diabetes among men and women in China. N Engl J Med. 362:1090–1101. 2010. View Article : Google Scholar : PubMed/NCBI
2	Mbanya JC, Motala AA and Sobngwi E: Diabetes in sub-Saharan Africa. Lancet. 375:2254–2266. 2010. View Article : Google Scholar : PubMed/NCBI
3	Jermendy G, Nadas J, Szigethy E, et al: Prevalence rate of diabetes mellitus and impaired fasting glycemia in Hungary: cross-sectional study on nationally representative sample of people aged 20–69 years. Croat Med J. 51:151–156. 2010.PubMed/NCBI
4	Dieguez C, da Boit K, Novelle MG, et al: New insights in ghrelin orexigenic effect. Front Horm Res. 38:196–205. 2010. View Article : Google Scholar : PubMed/NCBI
5	De Vriese C, Perret J and Delporte C: Focus on the short- and long-term effects of ghrelin on energy homeostasis. Nutrition. 26:579–584. 2010.PubMed/NCBI
6	Zhang Y, Proenca R, Maffei M, Barone M, Leopold L and Friedman JM: Positional cloning of the mouse obese gene and its human homologue. Nature. 372:425–432. 1994. View Article : Google Scholar : PubMed/NCBI
7	Farooqi IS and O’Rahilly S: Leptin: a pivotal regulator of human energy homeostasis. Am J Clin Nutr. 89:S980–S984. 2009. View Article : Google Scholar : PubMed/NCBI
8	Coppari R, Ichinose M, Lee CE, et al: The hypothalamic arcuate nucleus: a key site for mediating leptin’s effects on glucose homeostasis and locomotor activity. Cell Metab. 1:63–72. 2005.
9	Cowley MA, Smith RG, Diano S, et al: The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron. 37:649–661. 2003. View Article : Google Scholar : PubMed/NCBI
10	Klok MD, Jakobsdottir S and Drent ML: The role of leptin and ghrelin in the regulation of food intake and body weight in humans: a review. Obes Rev. 8:21–34. 2007. View Article : Google Scholar : PubMed/NCBI
11	Klok K, Sone H and Yada T: Ghrelin is a physiological regulator of insulin release in pancreatic islets and glucose homeostasis. Pharmacol Ther. 118:239–249. 2008. View Article : Google Scholar : PubMed/NCBI
12	Reed MJ, Meszaros K, Entes LJ, et al: A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat. Metabolism. 49:1390–1394. 2000. View Article : Google Scholar : PubMed/NCBI
13	Zhang F, Ye C, Li G, et al: The rat model of type 2 diabetic mellitus and its glycometabolism characters. Exp Anim. 52:401–407. 2003. View Article : Google Scholar : PubMed/NCBI
14	Srinivasan K, Viswanad B, Asrat L, Kaul CL and Ramarao P: Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. Pharmacol Res. 52:313–320. 2005. View Article : Google Scholar : PubMed/NCBI
15	Islam MS and Choi H: Nongenetic model of type 2 diabetes: a comparative study. Pharmacology. 79:243–249. 2007. View Article : Google Scholar : PubMed/NCBI
16	Peterson RG, Shaw WN and Neel MA: Zucker diabetic fatty rat as a model for non-insulin-dependent diabetes mellitus. ILAR News. 32:16–19. 1990. View Article : Google Scholar
17	Chang AY: Spontaneous diabetes in animals. Gen Pharmacol. 9:447–450. 1978. View Article : Google Scholar
18	Woods SC, Seeley RJ, Rushing PA, D’Alessio D and Tso P: A controlled high-fat diet induces an obese syndrome in rats. J Nutr. 133:1081–1087. 2003.PubMed/NCBI
19	Ukkola O, Poykko S, Paivansalo M and Kesäniemi YA: Interactions between ghrelin, leptin and IGF-I affect metabolic syndrome and early atherosclerosis. Ann Med. 40:465–473. 2008. View Article : Google Scholar : PubMed/NCBI
20	Pacifico L, Poggiogalle E, Costantino F, et al: Acylated and nonacylated ghrelin levels and their associations with insulin resistance in obese and normal weight children with metabolic syndrome. Eur J Endocrinol. 161:861–870. 2009. View Article : Google Scholar : PubMed/NCBI
21	Serra-Prat M, Alfaro SR, Palomera E, et al: Relationship between ghrelin and the metabolic syndrome in the elderly: a longitudinal population-based study. Clin Endocrinol (Oxf). 70:227–232. 2009. View Article : Google Scholar : PubMed/NCBI
22	Sun Y, Asnicar M and Smith RG: Central and peripheral roles of ghrelin on glucose homeostasis. Neuroendocrinology. 86:215–228. 2007. View Article : Google Scholar : PubMed/NCBI
23	Yada T, Dezaki K, Sone H, et al: Ghrelin regulates insulin release and glycemia: physiological role and therapeutic potential. Curr Diabetes Rev. 4:18–23. 2008. View Article : Google Scholar : PubMed/NCBI
24	Dezaki K, Kakei M and Yada T: Ghrelin uses Galphai2 and activates voltage-dependent K⁺ channels to attenuate glucose-induced Ca²⁺ signaling and insulin release in islet beta-cells: novel signal transduction of ghrelin. Diabetes. 56:2319–2327. 2007.PubMed/NCBI
25	Wortley KE, del Rincon JP, Murray JD, et al: Absence of ghrelin protects against early-onset obesity. J Clin Invest. 115:3573–2578. 2005. View Article : Google Scholar : PubMed/NCBI
26	Zigman JM, Nakano Y, Coppari R, et al: Mice lacking ghrelin receptors resist the development of diet-induced obesity. J Clin Invest. 115:3564–3572. 2005. View Article : Google Scholar : PubMed/NCBI
27	Flanagan DE, Evans ML, Monsod TP, et al: The influence of insulin on circulating ghrelin. Am J Physiol Endocrinol Metab. 284:E313–E316. 2003. View Article : Google Scholar : PubMed/NCBI
28	Ueno M, Carvalheira JB, Oliveira RL, Velloso LA and Saad MJ: Circulating ghrelin concentrations are lowered by intracerebroventricular insulin. Diabetologia. 49:2449–2452. 2006. View Article : Google Scholar : PubMed/NCBI
29	Fick LJ, Cai F and Belsham DD: Hypothalamic preproghrelin gene expression is repressed by insulin via both PI3-K/Akt and ERK1/2 MAPK pathways in immortalized, hypothalamic neurons. Neuroendocrinology. 89:267–275. 2009. View Article : Google Scholar : PubMed/NCBI
30	Nogueiras R, Tovar S, Mitchell SE, et al: Regulation of growth hormone secretagogue receptor gene expression in the arcuate nuclei of the rat by leptin and ghrelin. Diabetes. 53:2552–2558. 2004. View Article : Google Scholar : PubMed/NCBI
31	Al-Shoumer KA, Al-Asousi AA, Doi SA and Vasanthy BA: Serum leptin and its relationship with metabolic variables in Arabs with type 2 diabetes mellitus. Ann Saudi Med. 28:367–370. 2008. View Article : Google Scholar : PubMed/NCBI
32	Levin BE, Dunn-Meynell AA, Ricci MR and Cummings DE: Abnormalities of leptin and ghrelin regulation in obesity-prone juvenile rats. Am J Physiol Endocrinol Metab. 285:E949–E957. 2003. View Article : Google Scholar : PubMed/NCBI
33	Myers MG, Cowley MA and Munzberg H: Mechanisms of leptin action and leptin resistance. Annu Rev Physiol. 70:537–556. 2008. View Article : Google Scholar : PubMed/NCBI